
Search by job, company or skills
Work Schedule
Standard (Mon-Fri)Environmental Conditions
OfficeThe Immunodiagnostics Division (IDD) of Thermo Fisher Scientific aims to dramatically improve the management of allergy, asthma, and autoimmune diseases by providing healthcare professionals with advanced diagnostics technologies and clinical expertise. Our key businesses: allergy, autoimmunity, and systems. This role will be part of the Global Downstream Marketing team.
We're seeking a scientifically trained content writer to help develop global marketing materials that communicate the value of our immunodiagnostic solutions to healthcare professionals, clinical laboratory audiences, and patients. This role combines scientific expertise with strong English writing skills to craft accurate, compliant, and engaging content. As a part of the Global Downstream Marketing team, this person will help translate complex immunodiagnostic information into meaningful content that drives understanding and impact across diverse markets.
The ideal candidate has a strong foundation in the life sciences, exceptional writing ability, and a keen understanding of how to create credible, high-quality marketing content that drives engagement while meeting regulatory and brand standards.
What will you do
We offer competitive remuneration, annual incentive plan bonus, healthcare, and a range of employee benefits. Thermo Fisher Scientific offers employment with an innovative, forward-thinking organization, and outstanding career and development prospects. We offer an exciting company culture that stands for integrity, intensity, involvement, and innovation!
Thermo Fisher Scientific Inc. is an American supplier of scientific instrumentation, reagents and consumables, and software services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including: Life Technologies Corporation (2013), Alfa Aesar (2015),Affymetrix (2016),FEI Company (2016), BD Advanced Bioprocessing (2018),and PPD (2021).
As of 2017, the company had a market capitalization of $21 billion and was a Fortune 500 company. Annual revenue in 2021 was US$39.21 billion.
In March 2020, Thermo Fisher Scientific received emergency use authorization from the FDA for a test for SARS-CoV-2 to help mitigate the COVID-19 pandemic.
Job ID: 134396105